Clinical Trial

Nimotuzumab Combined With Toripalimab and Chemotherapy for Locally Advanced Tonsillar Cancer

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This is a prospective,single-arm,Phase II clinical study to designed to evaluate the efficancy and safety of nimotuzumab Combined with Toripalimab and Chemotherapy for Locally Advanced Tonsillar Cancer
Trial Details
NCT Number NCT07353723
Lead Sponsor Tang-Du Hospital
Conditions Head & Neck Cancer
Enrollment 10 participants
Start Date 2025-11-15
Primary Completion 2026-11-15 (estimated)
Study Completion 2031-11-30 (estimated)
Updated on ClinicalTrials.gov 2026-01-20